首页|miR-142-3p和miR-497-5p在妊娠期糖尿病患者血清中的表达及诊断价值

miR-142-3p和miR-497-5p在妊娠期糖尿病患者血清中的表达及诊断价值

扫码查看
目的 检测妊娠期糖尿病(GDM)患者血清微小RNA(miR)-142-3p、miR-497-5p表达水平,分析其对GDM的诊断价值.方法 选取2019年6月-2022年6月在河南中医药大学第五临床医学院妇产科行产前检查的142例GDM孕妇作为GDM组,另外随机选择一般资料与GDM组匹配的142名正常糖耐量孕妇作为对照组.比较两组孕妇血清miR-142-3p、miR-497-5p水平,使用受试者工作特征(ROC)曲线分析血清miR-142-3p、miR-497-5p水平对孕妇发生GDM的评估价值.结果 与对照组比较,GDM组患者miR-142-3p水平、有糖尿病史占比、经产妇占比、空腹血糖(FPG)、餐后2h血糖(2hPG)、空腹胰岛素(FINS)、糖化血红蛋白(HbA1c)、胰岛素抵抗指数(HOMA-IR)升高,血清miR-497-5p水平显著降低,差异均有统计学意义(t=8.303、6.818、9.551、8.781、9.054、6.464、9.475、11.671、7.883,P均<0.05).miR-142-3p、miR-497-5p联合检测预测孕妇发生GDM的ROC曲线下面积(AUC)为0.838,敏感性为73.24%,特异性为82.39%,优于各自单独诊断(Z=4.379、3.170,P均<0.01).结论 GDM患者血清miR-142-3p表达显著上调、miR-497-5p表达显著下调,二者联合对孕妇是否发生GDM有较好的预测价值.
Expression and clinical significance of miR-142-3p and miR-497-5p in serum of pregnant women with diabetes
Objective To investigate the expression and clinical significance of miR-142-3p and miR-497-5p in the serum of women with gestational diabetes mellitus(GDM).Methods A total of 142 pregnant women with GDM who underwent prenatal examinations in the Fifth Clinical College Medical Henan University of Chinese Medicine obstetrics and gynecology department from June 2019 to June 2022 were collected as research subjects(GDM group);in addition,142 pregnant women with normal glucose tolerance who matched the GDM group with general data were randomly selected as the control group.The serum levels of miR-142-3p and miR-497-5p were measured and compared between the two groups.Receiver operating characteristic(ROC)curve was applied to analyze the value of serum miR-142-3p and miR-497-5p levels in evaluating GDM in pregnant women.Results Compared with the control group,the level of miR-142-3p,the proportion of patients with diabetes history,the proportion of multiparous woman,fasting blood glucose(FPG),2 h postprandial blood glucose(2 h PG),fasting insulin(FINS),glycosylated hemoglobin(HbA1c),and insulin resistance index(HOMA-IR)in GDM group were obviously higher,the level of serum miR-497-5p was obviously lower,the differences were statistically significant(t=8.303,6.818,9.551,8.781,9.054,6.464,9.475,11.671,7.883;all P<0.05).The area under the ROC curve(AUC)of the combined detection of miR-142-3p and miR-497-5p for predicting GDM in pregnant women was 0.838,with a sensitivity of 73.24%,and a specificity of 82.39%,which was superior to their respective independent diagnosis(Z=4.379,3.170;all P<0.01).Conclusions The expression of miR-142-3p in serum of patients with GDM was obviously up-regulated,and the expression of miR-497-5p was obviously down-regulated.The combination of the two had a good reference value in predicting the occurrence of GDM in pregnant women.

Gestational diabetes mellitusmicroRNA-142-3pmicroRNA-497-5p

段杨平、章珊珊、卢晓莉、刘伟靓、林星光

展开 >

河南中医药大学第五临床医学院(郑州人民医院)产科,河南郑州 450000

华中科技大学同济医学院附属同济医院产科,湖北武汉 430030

妊娠期糖尿病 微小RNA-142-3p 微小RNA-497-5p

湖北省科技厅自然科学基金

2019CFB546

2024

热带医学杂志
广东省寄生虫学会 中华预防医学会

热带医学杂志

CSTPCD
影响因子:0.643
ISSN:1672-3619
年,卷(期):2024.24(7)
  • 7